Elle Eunyounglee Kim is a pharmacist who is specialized in Oncology in Fresno, California. Patients can reach her at 7300 N Fresno St, Fresno or contact her on 559-448-4500. Active license number of Elle Eunyounglee Kim is 58061 for Oncology in California. Elle Eunyounglee Kim is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Elle Eunyounglee Kim speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Elle Eunyounglee Kim
Specialization:
Oncology
Credentials:
RPH
Gender:
Female
Location:
7300 N Fresno St, Fresno, California, 93720
Phone:
559-448-4500
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Elle Eunyounglee Kim are as mentioned below.
NPI Number:
1841718483
NPI Enumeration Date:
05 Sep, 2017
NPI Last Update On:
04 Mar, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elle Eunyounglee Kim are as mentioned below.
Specialization
License Number
State
Status
Oncology
58061
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7300 N Fresno St, Fresno, California
Zip:
93720-2941
Phone Number:
559-448-5290
Fax Number:
--
Patients can reach Elle Eunyounglee Kim at 7300 N Fresno St, Fresno, California or can call on phone at 559-448-4500.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.